Is There a Survival Advantage in Diagnosing Endometrial Cancer in Asymptomatic Patients? A Systemic Review and Meta-analysis

MLA

Ofer Lavie, et al. “Is There a Survival Advantage in Diagnosing Endometrial Cancer in Asymptomatic Patients? A Systemic Review and Meta-Analysis.” Journal of Obstetrics and Gynaecology Canada, vol. 42, Apr. 2020, p. 481–487.e2. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48ef3de03b7a520aeabf9018a7c88807&authtype=sso&custid=ns315887.

APA

Ofer Lavie, Lena Dain-Sagi, Yakir Segev, Ofer Gemer, & Shlomi Sagi. (2020). Is There a Survival Advantage in Diagnosing Endometrial Cancer in Asymptomatic Patients? A Systemic Review and Meta-analysis. Journal of Obstetrics and Gynaecology Canada, 42, 481–487.e2.

Chicago

Ofer Lavie, Lena Dain-Sagi, Yakir Segev, Ofer Gemer, and Shlomi Sagi. 2020. “Is There a Survival Advantage in Diagnosing Endometrial Cancer in Asymptomatic Patients? A Systemic Review and Meta-Analysis.” Journal of Obstetrics and Gynaecology Canada 42 (April): 481–487.e2. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48ef3de03b7a520aeabf9018a7c88807&authtype=sso&custid=ns315887.